Dr. Reddy’s Laboratories has launched Duloxetine Delayed-Release Capsules USP 20 mg, 30 mg and 60 mg, a therapeutic equivalent generic version of Cymbalta (Duloxetine Delayed-Release Capsules) in the US market. Dr. Reddy’s ANDA is approved by the United States Food & Drug Administration (US FDA).
The Cymbalta brand and generic had US sales of approximately $5.04 Billion MAT for the most recent twelve months ending in April 2014 according to IMS Health.
Dr. Reddy’s Duloxetine Delayed-Release Capsules USP 20 mg, 30 mg and 60 mg are available in several bottle counts.